Floatz logo

Balstilimab

Stage IV Colon Cancer AJCC v8

City of Hope Medical Centermonoclonal_antibodyPhase 2Active
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Stage IV Colon Cancer AJCC v8 cohort.

Asset / SponsorPhaseRating
Botensilimab
City of Hope Medical Center
Phase 2B

Same molecule, other indications

Balstilimab is also rated in:

colorectal adenocarcinomaDormant
BB
Indicative ·
66 / 100
View asset →
Metastatic Colorectal AdenocarcinomaDormant
B
Indicative ·
62 / 100
View asset →
colorectal carcinomaDormant
B
Indicative ·
60 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →